首页/数据集/Clinical outcomes in LAM and LAM+ADV groups.

Clinical outcomes in LAM and LAM+ADV groups.

NIAID Data Ecosystem2026-03-09 收录

淋巴管平滑肌瘤病

临床结局比较

数据链接：

https://figshare.com/articles/dataset/Clinical_outcomes_in_LAM_and_LAM_ADV_groups_/3998283 数据链接链接失效反馈

官方服务：

资源简介：

Clinical outcomes in LAM and LAM+ADV groups.

应用场景：

创建时间：

2016-10-12

肺移植

淋巴管平滑肌瘤病

Background Lung transplantation has been established as the definitive treatment option for patients with advanced lymphangioleiomyomatosis (LAM). However, the prognosis after registration and the cir

NIAID Data Ecosystem70

Comparison between survivors and non survivors in critically ill COVID-19 patients.

COVID-19

临床结局比较

Comparison between survivors and non survivors in critically ill COVID-19 patients.

NIAID Data Ecosystem50

Clinical outcomes of East-Asian Covid-19 patients treated with ACEI/ARB vs. untreated subjects (all studies).

COVID-19干预

临床结局比较

Clinical outcomes of East-Asian Covid-19 patients treated with ACEI/ARB vs. untreated subjects (all studies).

NIAID Data Ecosystem40

Event and event rate in the overall study population and the comparative risks for clinical outcomes in propensity score-matched cohorts.

临床结局比较

倾向评分匹配

Event and event rate in the overall study population and the comparative risks for clinical outcomes in propensity score-matched cohorts.

Figshare2023-11-20 更新60

Patient outcomes within training and testing cohort.

临床队列分析

临床结局比较

Outcomes within the training and test cohort. Values are N (%). P values represent differences across the three test cohorts.

NIAID Data Ecosystem50

Clinical outcomes in LAM and LAM+ADV groups.

资源简介：

相关数据集